Meeder Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-2,015
| Closed | -$111K | – | 889 |
|
2022
Q3 | $111K | Buy |
2,015
+105
| +5% | +$5.78K | 0.01% | 667 |
|
2022
Q2 | $126K | Sell |
1,910
-606
| -24% | -$40K | 0.01% | 689 |
|
2022
Q1 | $167K | Buy |
+2,516
| New | +$167K | 0.01% | 691 |
|
2021
Q4 | – | Sell |
-3,292
| Closed | -$198K | – | 1258 |
|
2021
Q3 | $198K | Buy |
3,292
+2,888
| +715% | +$174K | 0.01% | 725 |
|
2021
Q2 | $24K | Buy |
404
+387
| +2,276% | +$23K | ﹤0.01% | 1397 |
|
2021
Q1 | $1K | Hold |
17
| – | – | ﹤0.01% | 2174 |
|
2020
Q4 | $1K | Hold |
17
| – | – | ﹤0.01% | 1596 |
|
2020
Q3 | $1K | Buy |
+17
| New | +$1K | ﹤0.01% | 1927 |
|
2019
Q3 | – | Sell |
-1,889
| Closed | -$78K | – | 2139 |
|
2019
Q2 | $78K | Buy |
+1,889
| New | +$78K | 0.01% | 821 |
|
2017
Q4 | – | Sell |
-3,079
| Closed | -$104K | – | 1654 |
|
2017
Q3 | $104K | Hold |
3,079
| – | – | 0.01% | 555 |
|
2017
Q2 | $105K | Buy |
+3,079
| New | +$105K | 0.01% | 552 |
|
2017
Q1 | – | Sell |
-3,384
| Closed | -$92K | – | 1653 |
|
2016
Q4 | $92K | Buy |
+3,384
| New | +$92K | 0.01% | 536 |
|